We are Sorry, This Page doesn't Exist
A gut-wrenching photo of a dead turtle stuck in fishing line puts the plastic problem in stark relief. The image won a prestigious award.
Shane Gross/Ocean Art A photo showing a dead Pacific green sea turtle caught in a piece of fishing line won an award in the Ocean Art Underwater Photo Competition. Abandoned fishing gear i.....»»
Innate Pharma drops 9% after FDA puts Tellomak trial on hold
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Flags Waving As Holiday Approaches, With Tesla Quarter Showing Unexpected Strength
Wall Street parades into July 4 with stocks at record highs and with jobs data and earnings season straight ahead. At the same time, small-cap stocks are lagging a bit and Treasury yields continue to forecast some caution. read more.....»»
Big Pharma Puts the Price Squeeze on Itself
Drugmakers are fighting for share in increasingly crowded markets of their own making......»»
California"s Kite Pharma plans to hire hundreds at new Frederick facility
Los Angeles biopharmaceutical company Kite Pharma plans to open a new manufacturing facility in Frederick County that will produce cell therapies for people with cancer. The company, a subsidiary of Gilead Sciences (NASDAQ: GILD), will build its.....»»
U.S. puts 37 Chinese companies and schools on red-flag "unverified" list
The U.S. Commerce Department said on Wednesday that is adding 37 Chinese companies and schools to a red-flag list of "unverified" entities that U.S. companies should treat with caution, according to a notice in the Federal Register......»»
North Korea Puts Clocks Back 30 Minutes to Get in Sync With Seoul
Kim Jong Un said it was painful to see the clocks in the summit room last week showing different times for the two countries......»»
Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions
Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions.....»»
Small-Cap Biotechs Developing Novel Gene Therapies Could Become Targets of Big Pharma
The acquisition of Kite Pharmaceuticals by Gilead and Juno Therapeutics by Celgene may lead to more acquisitions of CAR-T gene therapy companiesRelated Stocks: GILD, NVS, CELG, MBIO, CYAD, CLLS, PFE, BLCM,.....»»
Small Caps, Technology and Pharma To Drive A Renewed Market Rally
We've been warning our followers not to become frightened by price rotation in the US majors for months. Our predictive analysis has been showing ........»»
Netflix Plunges More Than 4% Ahead of Earnings
Wall Street believes the streaming service could take over entertainment - but some investors are showing caution. Netflix stock dropped a dizzying 4.28% on Friday, wiping out the stock's.....»»
Marijuana News Today: Is Medical Marijuana the New Pharma Industry?
Marijuana News Today The marijuana news today puts the medical marijuana industry in a whole new light as the first ever U.S. Food and Drug Administration (FDA)-approved cannabis p.....»»
Teva Pharma puts active as shares attempt to recover losses
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
This cancer-fighting biotech sped from startup to IPO filing in 10 months
The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»
More Caution Ahead in Top Semiconductor Companies
These were five of the top analyst calls showing caution in the semiconductor stocks from Tuesday, September 24, 2018......»»
Pharma Remains The Key Debate For Johnson & Johnson, But Other Segments Showing Signs Of A Recovery
Pharma Remains The Key Debate For Johnson & Johnson, But Other Segments Showing Signs Of A Recovery.....»»
Kite Pharma announces updated Zuma-3 data from KTE-X19 Phase 1/2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead’s Kite Failure Shows Dangers of Speculation Even at the Top Tier
Gilead bought CAR-T firm Kite Pharma for nearly $12 billion in 2017. Now, after an $820 million write-down on one Kite asset, some analysts say Gilead may have to write down the whole thingRelated Stocks: GILD, BLUE,.....»»
Bitcoin Up 3%: What Will Inflation Data And Powell Speech Bring This Week?
Bitcoin (CRYPTO: BTC) is carefully maintaining the $60,000 support level, navigating a delicate balance between bullish optimism and bearish caution. read more.....»»